Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed Absi

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Current Treatment Options in Oncology|May 5, 2005
Prolymphocytic leukemiaAhmed Absi, Eric Hsi, Matt Kalaycio
Multiple Sclerosis and Related Disorders|July 28, 2018
Adult-onset hemophagocytic lymphohistiocytosis type 2 presenting as a demyelinating diseaseHussein Algahtani, Ahmed Absi, Wafaa Bassuni, et al.
JAMA Network Open|March 4, 2020
Analysis of Patient-Physician Concordance in the Understanding of Chemotherapy Treatment Plans Among Patients With CancerHani Almalki, Ahmed Absi, Abdulrahman Alghamdi, et al.
The International Journal of Neuroscience|November 30, 2021
Hyperferritinemia with iron deposition in the basal ganglia and tremor as the initial manifestation of follicular lymphomaHussein Algahtani, Ahmed Absi, Bader Shirah, et al.
Leukemia & Lymphoma|December 11, 2007
Biologic predictors in follicular lymphoma: importance of markers of immune responseTodd Kelley, Rose Beck, Ahmed Absi, et al.
Cureus|June 20, 2022
The Impact of Obesity on Hodgkin's Lymphoma Patients Treated With Uniform Chemotherapy Protocol at Princess Noorah Oncology Center, National Guard Health Affairs, Jeddah, Saudi Arabia: Retrospective Matched CohortAlaa T Alsharif, Mohammed Aldawsari, Emad M Babateen, et al.
Pharmacy (Basel, Switzerland)|June 25, 2025
Real-World Evidence Assessing the Safety of Administering Intravenous Rituximab Biosimilar in the First Cycle and Subcutaneous Rituximab in Subsequent Cycles in B-Cell Lymphoma PatientsTamather Almandeel, Mansoor Ahmed Khan, Ashwag Algethami, et al.
Frontiers in Medicine|January 30, 2026
Clinical practice guidelines for the diagnosis and management of chronic lymphocytic leukemia in Saudi Arabia: consensus statement by an expert panelGhazi Alotaibi, Aamer Aleem, Ahmed Absi, et al.
Molecular and Clinical Oncology|November 7, 2022
Outcomes of high‑dose methotrexate for CNS prophylaxis in diffuse large B‑cell lymphoma with an intermediate or high CNS‑International Prognostic Index: A single‑center retrospective cohort studyMubarak Al-Mansour, Ahmed Absi, Roula Al-Μufti, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2023
The Outcomes of Diffuse Large B-cell Lymphoma Patients with Synchronous and Early Central Nervous System Involvement: A Single-Center ExperienceMubarak Al-Mansour, Saif Ahmed Saif, Ziyad Alharbi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Current Treatment Options in Oncology|May 5, 2005
Prolymphocytic leukemiaAhmed Absi, Eric Hsi, Matt Kalaycio
Multiple Sclerosis and Related Disorders|July 28, 2018
Adult-onset hemophagocytic lymphohistiocytosis type 2 presenting as a demyelinating diseaseHussein Algahtani, Ahmed Absi, Wafaa Bassuni, et al.
JAMA Network Open|March 4, 2020
Analysis of Patient-Physician Concordance in the Understanding of Chemotherapy Treatment Plans Among Patients With CancerHani Almalki, Ahmed Absi, Abdulrahman Alghamdi, et al.
The International Journal of Neuroscience|November 30, 2021
Hyperferritinemia with iron deposition in the basal ganglia and tremor as the initial manifestation of follicular lymphomaHussein Algahtani, Ahmed Absi, Bader Shirah, et al.
Leukemia & Lymphoma|December 11, 2007
Biologic predictors in follicular lymphoma: importance of markers of immune responseTodd Kelley, Rose Beck, Ahmed Absi, et al.
Cureus|June 20, 2022
The Impact of Obesity on Hodgkin's Lymphoma Patients Treated With Uniform Chemotherapy Protocol at Princess Noorah Oncology Center, National Guard Health Affairs, Jeddah, Saudi Arabia: Retrospective Matched CohortAlaa T Alsharif, Mohammed Aldawsari, Emad M Babateen, et al.
Pharmacy (Basel, Switzerland)|June 25, 2025
Real-World Evidence Assessing the Safety of Administering Intravenous Rituximab Biosimilar in the First Cycle and Subcutaneous Rituximab in Subsequent Cycles in B-Cell Lymphoma PatientsTamather Almandeel, Mansoor Ahmed Khan, Ashwag Algethami, et al.
Frontiers in Medicine|January 30, 2026
Clinical practice guidelines for the diagnosis and management of chronic lymphocytic leukemia in Saudi Arabia: consensus statement by an expert panelGhazi Alotaibi, Aamer Aleem, Ahmed Absi, et al.
Molecular and Clinical Oncology|November 7, 2022
Outcomes of high‑dose methotrexate for CNS prophylaxis in diffuse large B‑cell lymphoma with an intermediate or high CNS‑International Prognostic Index: A single‑center retrospective cohort studyMubarak Al-Mansour, Ahmed Absi, Roula Al-Μufti, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|February 28, 2023
The Outcomes of Diffuse Large B-cell Lymphoma Patients with Synchronous and Early Central Nervous System Involvement: A Single-Center ExperienceMubarak Al-Mansour, Saif Ahmed Saif, Ziyad Alharbi, et al.
Pageof 2